期刊文献+

2012年河南省人民医院200例肿瘤患者化疗药应用合理性分析 被引量:4

Rationality in The Use of Chemotherapeutic Drugs for Patients with Tumor in Henan Provincial People's Hospital in 2012: Analysis of 200 Cases
下载PDF
导出
摘要 目的:了解我院肿瘤患者化疗药使用情况,为临床合理用药提供参考。方法:随机抽取我院2012年200例肿瘤患者化疗病例,对其中不合理用药情况进行点评、分析。结果:共有44例患者存在用药不合理现象,主要表现为适应证不适宜、用药顺序错误、用法与用量不适宜及化疗方案不合理。结论:我院肿瘤患者化疗药不合理使用现象较为普遍,临床药师应及时将点评结果反馈给临床,对不合理用药行为进行干预与提醒,共同促进药物合理使用。 OBJECTIVE : To investigate the use of chemotherapeutic drugs for patients with tumor in our hospital so as to provide reference for clinical rational use of drugs. METHODS : 200 medical records of patients with tumor were randomly sampled in 2012 from our hospital for evaluation and analysis regarding the irrational prescriptions. RESULTS: Irrational drug use was noted in 44 cases, which manifested as improper in indications, wrong order in drug administration, improper in usage & dosage or irrational in chemotherapy regimen. CONCLUSION: The phenomenon of irrational use of chemotherapeutic drugs was very common in our hospital. Clinical pharmacists should timely report the results of prescription comment to clinicians meanwhile providing intervention and warning on their irrational drug use behavior so as to promote rational use of drugs together with clinicians.
机构地区 河南省人民医院
出处 《中国医院用药评价与分析》 2013年第11期983-985,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 化疗药 合理性 分析 Chemotherapeutic drugs Rationality Analysis
  • 相关文献

参考文献11

  • 1Weissman CH, Reynolds CH, Neubauer MA, et al. A phase Ⅲ randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patientswith advanced non-small cell lung cancer [ J ]. J Thorac Oncol,2011,6( 2 ) :358-364.
  • 2Atmaca A, A1-Batran SE, Wemer D, et al. A randomised multicentre phase Ⅱ study with cisplatin/doeetaxel vs oxaliplatin/docetaxel as first-line therapy inpatients with advanced or metastatic non-small cell lung cancer[ J]. Br J Cancer, 2013,108 (2) :265-270.
  • 3Raez LE, Kobina S, Santos ES. Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer[ J ]. Clin Lung Cancer ,2010,11 ( 1 ) : 18-24.
  • 4Kuo DY, Blank SV, Christos PJ, et al. Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study [ J ]. Gynecol Oncol, 2010,116(3) :442-446.
  • 5Nomura H, Aoki D, Takahashi F, et al. Randomized phase Ⅱ study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel pluscarboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic OncologyGroup study (JGOG2041)[ J ]. Ann Oncol, 2011,22 ( 3 ) : 636 -642.
  • 6Fracasso PM, Blessing JA, Molpus KL, et al. Phase Ⅱ study of oxaliplatin as second-line chemotherapy in endometrial carcinoma :a Gynecologic Oncology Group study [ J ]. Gynecol 0ncoi,2006,103 ( 2 ) :523-526.
  • 7Rowinsky EK, Gilbert MR, McGuire WP, et al. Sequences of taxol and cisplatin: a phase I and pharmacologic study [ J ]. J Clin Oncol, 1991,9 (9) : 1692-703.
  • 8Qin B, Tanaka R, Shibata Y, et al. In-vitro schedule- dependent interaction between oxaliplatin and 5-fluo- rouracil in human gastric cancer cell lines [ J ]. Anticancer Drugs, 2006,17 ( 4 ) : 445 -453.
  • 9Koizumi W, Kurihara M, Hasegawa K, et al. Sequence- dependence of eisplatin and 5-fluorouracil in advanced and recurrent gastric cancer[J]. Oncol Rep,2004,12(3 ) :557- 561.
  • 10Scagliotti GV,Parikh P,von Pawel J,et al. Phase Ⅱ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naivepatients with advanced- stage non-small-cell lung cancer[J]. J Clin Oncol,2008, 26(21 ) :3543-3551.

同被引文献25

  • 1陈邦银,孙新国,唐志江,李付红,彭金花.丙氨酰谷氨酰胺与葡萄糖或氯化钠注射液的配伍稳定性考察[J].中国药师,2009,12(2):245-246. 被引量:33
  • 2刘震天,陈颖兰.长春瑞宾联合顺铂、卡铂、奥沙利铂在治疗晚期非小细胞肺癌的比较[J].实用临床医学(江西),2006,7(10):61-62. 被引量:5
  • 3Cataldo VD, Gibbons DL, Perez-Soler R, et al. Treatment of non-small-cell lung cancer with erlotinib or gefitinib[ J]. N Engl J Med,2011,364(10) :947.
  • 4Peters S, Adjei AA, Gridelli C, et al. Metastatic non-small- cell lung cancer (NSCLC) : ESMO clinical practice guide- lines for diagnosis, treatment and follow-up [ J ]. Ann On- col ,2012,23 ( Suppl 7 ) : vii56.
  • 5Bidoli P,Zilembo N, Cortinovis D, et al. Randomized phase 11 three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer: an Italian trials in medical oncology study [ J ]. ~nn Onco1,2007,18 (3) :461.
  • 6Scagliotti GV,Kortsik C, Dark GG, et al. Pemetrexed com- bined with oxaliplatin or earboplatin as first-line treatment in advanced non-small cell lung cancer a multicenter, ran- domized, phase 11 trial [ J ]. Clinical Cancer Research, 2005,11 (2) :690.
  • 7Weissman CH, Reynolds CH, Neubauer MA, et al. A phase I11 randomized trial of gemcitabine-oxaliplatin versus earbo- platin-paclitaxel as first-line therapy in patients with ad- vanced non-small cell lung cancer [ J ]. J Thorac Oncol, 2011,6(2) :358.
  • 8Pich~ N, Leblond FA,Sid6ris L,et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperito- neal oxaliplatin using a murine model[ J]. Ann Surg,2011 , 254(1) :138.
  • 9卜一珊,徐彦贵,高仲阳.临床药师开展药学监护工作的新切入点分析[J].中国医院药学杂志,2008,28(9):742-743. 被引量:20
  • 10葛敏,彭海鹰.多西紫杉醇联合奥沙利铂治疗晚期非小细胞肺癌临床分析[J].河北医药,2008,30(11):1704-1705. 被引量:3

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部